NSE: GLENMARK
GLENMARK PHARMACEUTICALS
Latest available quote
GLENMARK PHARMACEUTICALS
NSE: GLENMARK
₹2,594.90
+4.90 (+0.19%)
Open
2,600.00
High
2,618.10
Low
2,572.50
Prev close
2,590.00
Last trade 8/11/2026, 3:50:22 pm IST. Last successful check 8/11/2026, 10:32:25 pm IST. Prices from NSE via Upstox, checked every 30 seconds; provider delays may apply. For information only.
Price history
+16.40% over 3M
Performance
52-week range
Position in day range
GLENMARK stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹2,368.01
RSI (14)
79
Overbought zone
Volatility (ATR)
3.64%
Moderate
Close streak
1d up
Volume vs 20d avg
0.13x
From 52W high
-3.27%
Up from 52W low
+44.05%
Green days (20)
12/20
Monthly seasonality
Average monthly move for GLENMARK across the available price history.
Key statistics
Open
2,600
Day high
2,618.1
Day low
2,572.5
Prev close
2,590
Volume
1.12 L
Avg vol (20d)
8.42 L
52W high
2,682.5
52W low
1,807
GLENMARK quarterly results
All GLENMARK results →Next results date
Awaiting intimation
Last results date
5 Nov 2026
Reports published
1 quarter covered
Revenue
₹4,157 cr
-30.8% YoY
Net profit
₹264 cr
-56.8% YoY
Operating profit
₹683 cr
-69.2% YoY
EPS
₹9.35
-56.8% YoY
Swipe sideways to see all columns →
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q2 FY272026-09-30 | ₹4,157 cr | ₹683 cr | ₹264 cr | 16.4% | 6.3% | ₹9.35 | -56.8% | -45.4% |
| Q1 FY272026-06-30 | ₹3,932 cr | ₹632 cr | ₹483 cr | 16.1% | 12.3% | ₹17.11 | — | +60.2% |
| Q4 FY262026-03-31 | ₹3,760 cr | ₹615 cr | ₹301 cr | 16.3% | 8.0% | ₹10.68 | — | -25.2% |
| Q3 FY262025-12-31 | ₹3,888 cr | ₹715 cr | ₹403 cr | 18.4% | 10.4% | ₹14.29 | — | -33.9% |
| Q2 FY262025-09-30 | ₹6,004 cr | ₹2,218 cr | ₹610 cr | 36.9% | 10.2% | ₹21.63 | — | — |
| TTM (last 4 quarters) | ₹15,737 cr | ₹2,645 cr | ₹1,451 cr | 16.8% | 9.2% | ₹51.43 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Glenmark Pharmaceuticals Limited Q2 FY27 Results: Net Profit ₹264 cr
Glenmark Pharmaceuticals Limited Q2 FY27 consolidated results: revenue from operations of ₹4,157 cr and net profit of ₹264 cr.
GLENMARK in Focus: Glenmark Pharmaceuticals Share Price Edges Up to ₹2,475.00 on Rising Newsflow
Glenmark Pharmaceuticals (GLENMARK) trades at ₹2,475.00, +13.60 (+0.55%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
GLENMARK in Focus: Glenmark Pharmaceuticals Share Price Opens Gap-Up at ₹2,486.90 on Rising Newsflow
Glenmark Pharmaceuticals (GLENMARK) trades at ₹2,441.60, -32.90 (-1.35%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Latest market news
Industry and Sectors Leads Market News Coverage with 8 Headlines
Financial newswires focused heavily on industry and sectors in the 8 November 2026 evening session, with gold and manufacturing following closely behind across major desks.
Industry and Sectors Tops Market Coverage on 8 November 2026
Financial newswires focused heavily on industry and sectors during the 8 November 2026 closing session, with technology and IT drawing strong desk coverage.
Industry and Sectors Tops Midday Market Talk on 8 November 2026
Financial news desks prioritize industry and sectors alongside manufacturing, technology, and energy as of 11:05 am IST on 8 November 2026 across major newswires.
Ethereum Price Drops 7.67% to $2,236.48 as Crypto Market Slides
Ethereum falls 7.67% to $2,236.48 as of 05:30 am IST on 8 November 2026, leading a broader sell-off across major digital assets including Bitcoin and XRP.
Morning Market Buzz, 8 November 2026: Quarterly Results Tops the Coverage Ahead of IPOs and Industry And Sectors
The most-covered market themes in the morning session on 8 November 2026 — quarterly results, IPOs, industry and sectors — with our live numbers for each and links to the publishers running the story.
Evening Market Focus on 7 November 2026: Industry and Sectors Leads
Industry and sectors tops desk coverage with 7 headlines across 4 publishers as of 07:05 pm IST on 7 November 2026, followed closely by IT and mutual funds.
Price and history data from NSE via Upstox. For information only, not investment advice.